EI
IART icon

EAM Investors’s Integra LifeSciences IART Stock Holding History

EAM Investors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-51,490
Closed -$2.81M – 310
2017
Q2 		$2.81M Buy
+51,490
New +$2.46M 0.46% 86
2016
Q4 		– Sell
-72,064
Closed -$2.97M – 334
2016
Q3 		$2.97M Sell
72,064
-1,876
-3% -$78.6K 0.4% 91
2016
Q2 		$2.95M Buy
+73,940
New +$2.66M 0.44% 68

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EAM Investors's IART Position: Q3 2017 in Review

EAM Investors sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 51,490 shares — an estimated $2.81M sold.

EAM Investors first reported a position in IART in Q2 2016 and held it in 3 quarters. The position peaked at $2.97M in Q3 2016. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

  • EAM Investors reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
  • EAM Investors sold 51,490 Integra LifeSciences shares in Q3 2017, an estimated $2.81M.
  • EAM Investors first reported a position in Integra LifeSciences in Q2 2016 and held it in 3 quarters.
  • EAM Investors's Integra LifeSciences position peaked at $2.97M in Q3 2016.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on EAM Investors's 13F filing for Q3 2017, filed 8 Nov 2017.